OLOCTINEBART
UNII KN8YN5E9D5

Substance Identification & Data

This profile provides standardized clinical and technical data for Oloctinebart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KN8YN5E9D5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2669063-84-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KN8YN5E9D5
CAS Registry Number
2669063-84-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OLOCTINEBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C199082
National Cancer Institute reference terminology for clinical and research data.
INN ID
12421
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oloctinebart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OLOCTINEBART

Common Names & Synonyms

IMMUNOGLOBULIN G4 (224-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN GALECTIN-3) (HUMAN-MUS MUSCULUS MONOCLONAL TB006 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TB006 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS LGALS3 (GALECTIN 3)), HUMANIZED MONOCLONAL ANTIBODY (GAMMA4 HEAVY CHAIN HUMANIZED (1-442) (VH (HOMO SAPIENS IGHV1-3*01 (88.7%) -(IGHD) -IGHJ6*01 (93.3%), CDR-IMGT (8.8.9) (26-33.51-58.97-105)) (1-116)-HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10 (CH1 (117-214), HINGE 1-12 S10>P (224)(215-226), CH2 L92 (305) (227-336), CH3 (337-441), CHS K2>DEL (442)) (117-442)), (130-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA(HOMO SAPIENS IGKV2D-29*02 (89.0%) -IGKJ2*01(100%), CDR-IMGT (11.3.9) (27-37.55-57.94-102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1(158), V101 (196) (113'-219')); DIMER (222-222'':225-225'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA)
OLOCTINEBART [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus